The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Antipsychotic Drugs, Neurotransmitters, and Schizophrenia
Abstract
Inhibition of central dopamine functions appears to be a common basic property of antipsychotic drugs. The mesolimbic and nigrostriatal portions of the dopaminergic system are probably the main targets for the mental and the extrapyramidal actions, respectively, of these drugs. The fact that dopaminergic hyperfunction induced by amphetamines or dopa may lead to a disturbance mimicking paranoid schizophrenia lends further support for a key role of dopamine in mental functions. Although a primary disturbance in dopamine function in schizophrenia cannot be ruled out, the intimate relationship between dopaminergic and other neuronal systems must be emphasized. The possible involvement of other amine, amino acid, or peptide transmitters in schizophrenia cannot be disregarded.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stereotaxic mapping of the monoamine pathways in the rat brain
Ungerstedt, U. (1971) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.1971.tb10998.x · Cited by 3,819
Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
Creese, I., Burt, D. R., & Snyder, S. H. (1976) · Science · doi:10.1126/science.3854 · Cited by 2,220
Carlsson, A., & Lindqvist, M. (1963) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1963.tb01730.x · Cited by 2,148
Self-citationDOPAMINERGIC NEURONS: EFFECT OF ANTIPSYCHOTIC DRUGS AND AMPHETAMINE ON SINGLE CELL ACTIVITY
BUNNEY, B. S., WALTERS, J. R., ROTH, R. H., & AGHAJANIAN, G. K. (1973) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29539-8 · Cited by 1,283
Receptor activity and turnover of dopamine and noradrenaline after neuroleptics
Andén, N.-E., Butcher, S. G., Corrodi, H., Fuxe, K., & Ungerstedt, U. (1970) · European Journal of Pharmacology · doi:10.1016/0014-2999(70)90006-3 · Cited by 1,026
Psychopharmacology. A Review of Progress, 1957-1967
Burger, A. (1969) · Journal of Medicinal Chemistry · doi:10.1021/jm00305a903 · Cited by 891
The Dopamine Hypothesis of Schizophrenia: A Review*
Meltzer, H. Y., & Stahl, S. M. (1976) · Schizophrenia Bulletin · doi:10.1093/schbul/2.1.19 · Cited by 883
Groves, P. M., Wilson, C. J., Young, S. J., & Rebec, G. V. (1975) · Science · doi:10.1126/science.242074 · Cited by 642
Aghajanian, G. K., & Bunney, B. S. (1977) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00508803 · Cited by 547
Dopamine in dendrites of substantia nigra neurons: suggestions for a role in dendritic terminals
Bjo¨rklund, A., & Lindvall, O. (1975) · Brain Research · doi:10.1016/0006-8993(75)90849-5 · Cited by 483
Clement-Cormier, Y. C., Kebabian, J. W., Petzold, G. L., & Greengard, P. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.4.1113 · Cited by 452
The Pharmacological Basis of Therapeutics.
Gemmill, C. L. (1966) · Journal of Medicinal Chemistry · doi:10.1021/jm00324a062 · Cited by 436
Dopamine-Sensitive Adenyl Cyclase: Possible Role in Synaptic Transmission
Kebabian, J. W., & Greengard, P. (1971) · Science · doi:10.1126/science.174.4016.1346 · Cited by 421
Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activity
Kehr, W., Carlsson, A., Lindqvist, M., Magnusson, T., & Atack, C. (1972) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1972.tb09104.x · Cited by 417
Self-citationAndén, N.-E., Roos, B.-E., & Werdinius, B. (1964) · Life Sciences · doi:10.1016/0024-3205(64)90196-1 · Cited by 408
Dopaminergic neurons: An in vivo system for measuring drug interactions with presynaptic receptors
Walters, J. R., & Roth, R. H. (1976) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00498834 · Cited by 350
Jackson, D. M., And�n, N.-E., & Dahlstr�m, A. (1975) · Psychopharmacologia · doi:10.1007/bf00429052 · Cited by 320
Drugs which block the storage of 5-hydroxytryptamine and related amines
Carlsson, A. (1966) · 5-Hydroxytryptamine and Related Indolealkylamines · doi:10.1007/978-3-642-85467-5_11 · Cited by 291
Self-citationEffect of clozapine on the turnover of dopamine in the corpus striatum and in the limbic system
Andén, N.-E., & Stock, G. (1973) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1973.tb10025.x · Cited by 291
Frontiers in neurology and neuroscience research
BROWN, G. (1973) · Physiology & Behavior · doi:10.1016/0031-9384(73)90364-8 · Cited by 269
MILLER, R. J., HORN, A. S., & IVERSEN, L. L. (1974) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13988-6 · Cited by 256
Andén, N.-E. (1972) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1972.tb08912.x · Cited by 236
AGHAJANIAN, G. K., & BUNNEY, B. S. (1973) · Frontiers in Catecholamine Research · doi:10.1016/b978-0-08-017922-3.50120-9 · Cited by 231
Central effects of an inhibitor of tyrosine hydroxylation
Corrodi, H., & Hanson, L. C. F. (1966) · Psychopharmacologia · doi:10.1007/bf00455973 · Cited by 220
Bartholini, G. (1976) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1976.tb04648.x · Cited by 177
Iversen, L. L., Rogawski, M. A., & Miller, R. J. (1976) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10755-4 · Cited by 164
Metoclopramide and dopamine receptor blockade
Peringer, E. (1976) · Neuropharmacology · doi:10.1016/0028-3908(76)90056-3 · Cited by 156
Bunney, B. S., & Achajanian, G. K. (1976) · Science · doi:10.1126/science.1257777 · Cited by 154
Živković, B., Guidotti, A., Revuelta, A., & Costa, E. (1975) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30226-0 · Cited by 147
Nybäck, H., & Sedvall, G. (1970) · European Journal of Pharmacology · doi:10.1016/0014-2999(70)90273-6 · Cited by 114
Ergometrine induced locomotor activity following intracerebral injection into the nucleus accumbens
Pijnenburg, A. J. J., Woodruff, G. N., & van Rossum, J. M. (1973) · Brain Research · doi:10.1016/0006-8993(73)90267-9 · Cited by 113
B�rki, H. R., Ruch, W., & Asper, H. (1975) · Psychopharmacology · doi:10.1007/bf00421302 · Cited by 106
Christiansen, J., & Squires, R. F. (1974) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1974.tb09293.x · Cited by 105
Bartholini, G., Stadler, H., Gadea-Ciria, M., & Lloyd, K. G. (1976) · Neuropharmacology · doi:10.1016/0028-3908(76)90101-5 · Cited by 97
Effect of apomorphine on schizophrenic symptoms
Smith, R. C., Tamminga, C. A., & Davis, J. M. (1977) · Journal of Neural Transmission · doi:10.1007/bf01250567 · Cited by 91
Wiesel, F., & Sedvall, G. (1975) · European Journal of Pharmacology · doi:10.1016/0014-2999(75)90123-5 · Cited by 80
Antipsychotic drugs and catecholamine synapses
Carlsson, A. (1974) · Journal of Psychiatric Research · doi:10.1016/0022-3956(74)90070-3 · Cited by 77
Self-citationStawarz, R. J., Hill, H. F., Robinson, S. E., et al. (1975) · Psychopharmacology · doi:10.1007/bf00421014 · Cited by 73
Andén, N., CORRODI, H., & Fuxé, K. (1972) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1972.tb08961.x · Cited by 70
Levodopa: Alterations in behavior
Goodwin, F. K., Murphy, D. L., Brodie, H. K. H., & Bunney, W. E. (1971) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1971122part2383 · Cited by 67
Wålinder, J., Skott, A., Carlsson, A., & Roos, B. E. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770040061011 · Cited by 66
Self-citationStudies of amine metabolites in affective illness and in schizophrenia: a comparative analysis.
Goodwin, F. K., & Post, R. M. (1975) · PubMed · Cited by 64
Effect of butaclamol on dopamine-sensitive adenylate cyclase in the rat striatum
Miller, R. J., Horn, A. S., & Iversen, L. L. (1975) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1975.tb09444.x · Cited by 39
Bs, B., & Aghajanian, G. K. (1977) · PubMed · Cited by 28
Antagonism by haloperidol of the L-DOPA-induced disruption of a successive discrimination in the rat
Ahlenius, S., & Engel, J. (1975) · Journal of Neural Transmission · doi:10.1007/bf01243436 · Cited by 22
Cited by
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
Weinberger, D. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800190080012 · Cited by 3,724
Glutamate receptor dysfunction and schizophrenia
Olney, J. W. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240016004 · Cited by 1,685
Dopamine receptors and the dopamine hypothesis of schizophrenia
Seeman, P. (1987) · Synapse · doi:10.1002/syn.890010203 · Cited by 880
Serotonin receptors : their key role in drugs to treat schizophrenia
Meltzer, H. Y., Li, Z., Kaneda, Y., & Ichikawa, J. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2003.09.010 · Cited by 775
Central D2-Dopamine Receptor Occupancy in Schizophrenic Patients Treated With Antipsychotic Drugs
Farde, L. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800250087012 · Cited by 692
Metadata
- Authors
- CARLSSON, A.
- Venue
- American Journal of Psychiatry
- Published
- 1978-02
- Volume
- 135
- Issue
- 2
- Pages
- 164-173
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2106926455
- Cited by
- 498
- References
- 45
- FWCI
- 25.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.